Tms (4891) · RiskRestated
Unexpected Adverse Effects and Product Liability
First written in FY2023. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Health Damage and Product Liability Risks Associated with PharmaceuticalsA theme 58 companies write about · 67 as a headwind · 1 as a tailwind
The whole theme swung hardest in 2026: 6 of 20 companies on the "Worse" side.
36 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「Pharmaceuticals may cause unexpected adverse effects from the clinical trial stage through after launch. In particular, when a product candidate is used by more people and for longer periods, adverse effects not observed in earlier trials may emerge.」
The Company reiterates the possibility that unexpected adverse effects may emerge from clinical trials through post-launch use, resulting in delays, discontinuation, additional trials, liability or reputational damage. - FY2023First statedAnnual report
「Pharmaceuticals may cause unexpected adverse effects from the clinical trial stage through after launch. In particular, when a product candidate is used by more people and for longer periods, adverse effects not observed in earlier trials may emerge.」
Unexpected adverse effects may emerge from clinical trials through post-launch use, potentially causing development delays or discontinuation, additional trials, liability and reputational damage.